Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $6.70 in the prior trading day, Relay Therapeutics Inc (NASDAQ: RLAY) closed at $6.51, down -2.84%. In other words, the price has decreased by -$2.84 from its previous closing price. On the day, 0.64 million shares were traded. RLAY stock price reached its highest trading level at $6.75 during the session, while it also had its lowest trading level at $6.5.
Ratios:
Our goal is to gain a better understanding of RLAY by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.64 and its Current Ratio is at 15.64. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
On April 20, 2023, Jefferies Upgraded its rating to Hold which previously was Underperform but kept the price unchanged to $12.50.
Raymond James Upgraded its Outperform to Strong Buy on April 19, 2023, while the target price for the stock was maintained at $29.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 31 ’24 when PETER J RAHMER bought 13,708 shares for $8.19 per share.
Rahmer Peter sold 13,708 shares of RLAY for $112,269 on Jul 31 ’24. The insider now owns 391,929 shares after completing the transaction at $8.19 per share. On Jul 30 ’24, another insider, PETER J RAHMER, who serves as the Officer of the company, bought 15,128 shares for $8.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 897065024 and an Enterprise Value of 234306672. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.76 while its Price-to-Book (P/B) ratio in mrq is 1.27. Its current Enterprise Value per Revenue stands at 6.655 whereas that against EBITDA is -0.637.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is -12.66%, while the 200-Day Moving Average is calculated to be -21.39%.
Shares Statistics:
The stock has traded on average 1.36M shares per day over the past 3-months and 1051840 shares per day over the last 10 days, according to various share statistics. A total of 127.46M shares are outstanding, with a floating share count of 120.36M. Insiders hold about 10.11% of the company’s shares, while institutions hold 71.89% stake in the company. Shares short for RLAY as of 1721001600 were 8429792 with a Short Ratio of 6.50, compared to 1718323200 on 9854750. Therefore, it implies a Short% of Shares Outstanding of 8429792 and a Short% of Float of 8.1599995.
